MedDataX Logo

Effect of Malnutrition on the Prognosis in Hemodialysis Patients

NCT ID: NCT00307983

Last Updated: 2006-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-04-30

Study Completion Date

2006-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examined the effect of malnutrition and/or inflammation on atherosclerosis and prognosis in hemodialysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Malnutrition is known to affect their prognosis in hemodialysis patients. Furthermore, recent studies indicate that malnutrition is associated with inflammation and atherosclerosis in these patients. In this study we examine the effect of malnutrition and/or inflammation on atherosclerosis and 5-year survival rate in 600 hemodialysis patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Renal Failure Hemodialysis Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hemodialysis for at least 6 months

Exclusion Criteria

* disabled patients
Minimum Eligible Age

0 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Shizuoka

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hiromichi Kumagai, MD

Role: STUDY_CHAIR

University of Shizuoka

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maruyama Hospital

Hamamatsu, Shizuoka, Japan

Site Status RECRUITING

Iwata City Hospital

Iwata, Shizuoka, Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hiromichi Kumagai, MD

Role: CONTACT

Phone: +81-54-264-5567

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Takako Takita, MD

Role: primary

Ryuichi Furuya, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CT2006002

Identifier Type: -

Identifier Source: org_study_id